Investor Presentaiton

Steady Focus on Balance Sheet continues Debtor Days 41 31 Mar-21 Mar-22 OCF to EBIDTA 106% 98% FY21 FY22 Rs. In Crs Working Capital Days 4 14 METROPOLIS The Pathology Specialist We have continued to focus on collection efficiency and improved our Debtor days ✓ Working capital days has increased slightly due to increase in inventory & decrease in creditors Mar-21 Mar-22 Cash and Cash Equivalents 428 181 ✓ Cash & Cash Equivalents dropped on account of utilization of cash for Hitech Acquisition ✓ Company undertook debt of Rs. 300 crs to fund Hitech Acquisition. Repaid Rs. 41 crs during FY22. Gross debt stood at Rs. 259 crs as of Mar-22. Plan to repay by FY24. ✓ OCF to EBITDA stood at 98% in FY22 slightly lower than last year due to increase in Working Capital Mar-21 Mar-22 = WC Days (CA - Cash & Equivalents) – (CL – Lease liabilities - Borrowings) / Sales *365 OCF / EBITDA = CFO before tax / EBITDA 17

View entire presentation